The Vall d’Hebron Research Institute (VHIR) has received two projects in the last call of the Associación Española Contra el Cáncer (AECC) to investigate stomach cancer and malignant melanoma. The projects, worth 1,200,000 euros each, are...
Read moreThe artist Josep Moscardó collaborates with VHIR by donating his Montjuïc Nit work
“Montjuïc nit” is the artist’s Josep Moscardó personal perspective of a set of emblematyc areas of Barcelona such as Montjuïc Hill, the Olympic ring on Montjuïc, the Paral·lel or the Port. Moscardó has donated a silk-screen printing edition...
Read moreVHIR researchers validate a new therapeutic target for colorectal cancer treatment
Researchers from the Group of Molecular Oncology CIBBIM-Nanomedicine at Vall d’Hebron Institute of Research (VHIR) have validated a gene, called PPOX, as a new therapeutic target against colorectal cancer. Furthermore, this study opens the door...
Read moreDiosgenin-based thio(seleno)ureas and triazolyl glycoconjugates as hybrid drugs. Antioxidant and antiproliferative profile
Simó Schwartz Navarro Romero-Hernández LL, Merino-Montiel P, Montiel-Smith S, Meza-Reyes S, Vega-Báez JL, Abasolo I, Schwartz S Jr, López Ó, Fernández-Bolaños JG. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY Pages : 99:67-81 Date : 2015-08...
Read moreVHIR researchers presented the results funded by the Marató of 2009 devoted to rare diseases
On Monday afternoon, 20 research projects funded by La Marató 2009 devoted to rare diseases were presented in the 16th Symposium La Marató of TV3, at the Institut d’Estudis Catalans’ facilities. There were researchers from Vall d’Hebron, who had...
Read moreVHIR proposals for Sant Jordi
Here you have our three recommendations for this Sant Jordi’s Day: ‘En Roc al Planeta Mascareta’, ‘Nano-Oncology, the Turning Point’ and ‘Aians’. These three books are written by professionals from Vall d’Hebron Hospital. En Roc al Planeta...
Read morePossible new strategies to combat epithelial metastatic cancer have been described
An article published by researchers from the School of Pharmacy of the University of Lisbon and from the Molecular Biology and Biochemistry Research Centre for Nanomedicine (CIBBIM-Nanomedicine) from the Vall d’Hebron Research Institute...
Read more